Literature DB >> 9950439

Association of two silent polymorphisms of platelet glycoprotein Ia/IIa receptor with risk of myocardial infarction: a case-control study.

K Moshfegh1, W A Wuillemin, M Redondo, B Lämmle, J H Beer, S Liechti-Gallati, B J Meyer.   

Abstract

BACKGROUND: The platelet membrane glycoprotein Ia/IIa plays a major part in platelet function as a primary receptor for collagen. A previous report showed a variation of glycoprotein Ia/IIa receptor density and function associated with two silent and linked polymorphisms (807C/T and 873G/A) within the glycoprotein Ia gene. Because platelet thrombus formation is implicated in the pathogenesis of acute myocardial infarction, we investigated these polymorphisms among patients who had had a myocardial infarction.
METHODS: We did a 2/1 case-control study including 177 patients (median age 57.0 [range 32-72] years) and 89 controls with same age and sex. Distributions of the 807C/T and 873G/A polymorphisms were investigated by genotyping DNA by PCR, single-strand conformation polymorphism analysis, and sequencing.
FINDINGS: The prevalence of the homozygous 807T/873A genotype was 2.9 times higher among patients with myocardial infarction than among controls (16.4% vs 5.6%, p=0.022). There was an association between patients homozygous for the 807T/873A allele and myocardial infarction (odds ratio 3.3 [95% CI 1.2-8.8]), which was strongest in a subgroup of smokers. The homozygous 807T/873A genotype remained an independent risk factor for myocardial infarction (p=0.005) when age, sex, smoking, hypertension, diabetes, body-mass index, LDL-cholesterol and HDL-cholesterol, and fibrinogen were adjusted for by logistic regression.
INTERPRETATION: The 807T/873A homozygosity of the platelet glycoprotein Ia/IIa gene polymorphism, associated with differences in surface collagen receptor density and activity, appears to be an independent risk factor for acute myocardial infarction. Our findings need to be confirmed in a larger, prospective study that includes patients from different populations and cardiovascular risk groups.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9950439     DOI: 10.1016/s0140-6736(98)06448-4

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  27 in total

Review 1.  Candidate genes and confirmed genetic polymorphisms associated with cardiovascular diseases: a tabular assessment.

Authors:  Z Tang; R P Tracy
Journal:  J Thromb Thrombolysis       Date:  2001-02       Impact factor: 2.300

2.  Glycoprotein Ia C807T gene polymorphism and increased risk of recurrent acute coronary syndromes: a five year follow up.

Authors:  A M Leone; V De Stefano; F Burzotta; P Chiusolo; I Casorelli; K Paciaroni; E Rossi; A Sciahbasi; L Testa; G Leone; F Crea; F Andreotti
Journal:  Heart       Date:  2004-05       Impact factor: 5.994

Review 3.  Role of platelet glycoprotein polymorphisms in cardiovascular diseases.

Authors:  Christian Meisel; José A López; Karl Stangl
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-11-12       Impact factor: 3.000

4.  Variants associated with common disease are not unusually differentiated in frequency across populations.

Authors:  Kirk E Lohmueller; Matthew M Mauney; David Reich; John M Braverman
Journal:  Am J Hum Genet       Date:  2005-11-16       Impact factor: 11.025

5.  hnRNP L regulates differences in expression of mouse integrin alpha2beta1.

Authors:  Yann Cheli; Thomas J Kunicki
Journal:  Blood       Date:  2006-02-02       Impact factor: 22.113

Review 6.  Proteomic approaches to dissect platelet function: Half the story.

Authors:  Dmitri V Gnatenko; Peter L Perrotta; Wadie F Bahou
Journal:  Blood       Date:  2006-08-22       Impact factor: 22.113

7.  Human platelet alloantigens HPA-1, HPA-2, and HPA-3 polymorphisms associated with extent of severe coronary artery disease.

Authors:  Nesrine Abboud; Lakdhar Ghazouani; Sonia Ben-Hadj-Khalifa; Fatma Anabi; Faouzi Added; Ali Khalfallah; Brahim Nsiri; Wassim Y Almawi; Touhami Mahjoub
Journal:  J Thromb Thrombolysis       Date:  2010-05       Impact factor: 2.300

8.  Class prediction models of thrombocytosis using genetic biomarkers.

Authors:  Dmitri V Gnatenko; Wei Zhu; Xiao Xu; Edward T Samuel; Melissa Monaghan; Mohammad H Zarrabi; Christi Kim; Anil Dhundale; Wadie F Bahou
Journal:  Blood       Date:  2009-09-22       Impact factor: 22.113

9.  Genetic variability in platelet integrin α2β1 density: possible contributor to Plasmodium vivax-induced severe thrombocytopenia.

Authors:  Fernanda M F Campos; Marina L S Santos; Flora S Kano; Cor J F Fontes; Marcus V G Lacerda; Cristiana F A Brito; Luzia H Carvalho
Journal:  Am J Trop Med Hyg       Date:  2012-12-18       Impact factor: 2.345

10.  Bloody tears and hematohidrosis in a patient of PF3 dysfunction: a case report.

Authors:  Kusum L Mishra
Journal:  Cases J       Date:  2009-09-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.